Estimated reading time: 2 minutes, 41 seconds

OneOncology Inc., a company that is uniting the oncology community, has announced that Therapeutics and Research in Oncology (TRIO) and its 50 plus member-practices in Maryland, Virginia and Washington, D.C. have registered with OneOncology to use its electronic negotiation platform to simplify oncology drug purchasing. TRIO joins more than 175 practices representing more than 650 physicians and $1.6 billion in annual purchasing already registered with OneOncology.


“We are honored to welcome TRIO and all its members to OneOncology,” said Steven Kirchof, CEO of OneOncology. “We look forward to working with TRIO in pursuit of our shared goal of uniting the oncology community to create a transparent, open market for oncology drug purchasing.”

OneOncology is an impartial electronic trading hub that aggregates individual drug orders from oncology practices across the country and allows drug distributors to bid to fill those orders at competitive prices. The technology provides complete transparency for the drug purchasing process, allows qualified U.S. distributors to participate in the growing oncology arena and enables oncologists to build healthier practices. OneOncology is uniting the oncology market to ensure community cancer care survives.

“OneOncology can help us secure more competitive pricing on oncology drugs while simplifying our drug purchasing process so that we can stay focused on our primary passion for patient care,” said TRIO Secretary Treasurer Ram Trehan, MD. “We hope all of the state societies, physicians, distributors and manufacturers across the country will join together with us to increase competition and transparency that will lower prices in the oncology market.”

“The issue of transparency in areas such as the wide variability of drug prices is significant concern. For example, among current practices that have registered with OneOncology, we have seen that there is a $98 difference between the lowest and highest off-invoice price paid for the exact same vial of drug. Even more surprising is the fact that the lowest price for many drugs is not always associated with the largest volume purchasers,” Kirchof said.

OneOncology benefits practices in many ways, including the opportunity to:
• Lower costs by letting the open market set drug prices through a completely transparent negotiation that ensures the lowest possible price on a product line item basis
• Free-up staff time spent on drug shopping, price negotiation, drug ordering and administrative tasks to give physicians greater freedom of choice in making treatment decisions and optimizing therapies
• Improve decision-making and efficiency with an easy-to-use online order management process and incorporation of inventory management technology

Distributors are also poised to benefit greatly from OneOncology's electronic negotiation technology. By registering with OneOncology and participating in the live negotiation events, distributors can access aggregated product demand from hundreds of registered practices, growing their business while reducing sales and marketing costs at the same time.

About OneOncology
OneOncology Inc. is a privately held corporation dedicated to uniting the oncology market to ensure that community cancer care survives. Through its electronic negotiation technology, the company simplifies the oncology drug supply chain, maximizes efficiency and minimizes costs for oncology practices, manufacturers, distributors and GPO’s. Based in Orlando, Fla., OneOncology is led by an experienced and skilled management team with deep backgrounds in community oncology.
www.OneOncology.com Last modified on Monday, 10 June 2013
Read 3625 times
Rate this item
(0 votes)

Visit other PMG Sites:

click me
PMG360 is committed to protecting the privacy of the personal data we collect from our subscribers/agents/customers/exhibitors and sponsors. On May 25th, the European's GDPR policy will be enforced. Nothing is changing about your current settings or how your information is processed, however, we have made a few changes. We have updated our Privacy Policy and Cookie Policy to make it easier for you to understand what information we collect, how and why we collect it.
Ok Decline